Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01808508 · ClinicalTrials.gov registry record · NA

Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome

A NA study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
27
Enrollment target

NCT01808508 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01808508, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

Many individuals with Down syndrome (DS) have breathing problems during sleep. This is called obstructive sleep apnea syndrome (OSAS). OSAS is very common in individuals with Down syndrome because of the shape of their face and tongue and because of their low muscle tone. OSAS can cause a lot of health problems including behavioral and learning problems as well as heart problems. The purpose of this research study is to look at the effects of treating OSAS in individuals with Down syndrome with a machine called Continuous Positive Airway Pressure (CPAP). The investigators want to see if treatment of OSAS improves learning, behavior and heart problems.

Interventions

  • DEVICE Continuous positive airway pressure
  • DEVICE Sham or placebo continuous positive airway pressure

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2010-09
Est. Completion 2014-09
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT01808508

The ClinicalTrials.gov registry entry for NCT01808508 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Continuous positive airway pressure is the first listed.

NCT01808508 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01808508 about?

NCT01808508 is a clinical study titled "Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome". Many individuals with Down syndrome (DS) have breathing problems during sleep. This is called obstructive sleep apnea syndrome (OSAS). OSAS is very common in individuals with Down syndrome because of the shape of their face and tongue and because of their low muscle tone. OSAS can cause a lot of hea...

What is the current status of trial NCT01808508?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2010-09. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01808508?

The interventions under investigation include: Continuous positive airway pressure (DEVICE), Sham or placebo continuous positive airway pressure (DEVICE).

Who is sponsoring clinical trial NCT01808508?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.